Beyond Air (XAIR) Profit After Tax Growth (3y) (2019 - 2026)

Beyond Air (XAIR) Profit After Tax Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (3y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -6.51%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 7.96%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 2.68%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 62.16%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 3.79%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 60.12%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 2.38%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 30.83%
10 Beyond Air 2.23 Mn -10.13 Mn 94,000.00 -38.12%

Historic Data

Download Data
DateValue
Mar 31, 2026 -38.12%
Dec 31, 2025 16.82%
Sep 30, 2025 13.59%
Jun 30, 2025 11.50%
Mar 31, 2025 -50.53%
Dec 31, 2024 -19.16%
Sep 30, 2024 -17.30%
Jun 30, 2024 -24.64%
Mar 31, 2024 -38.08%
Dec 31, 2023 -44.08%
Sep 30, 2023 -50.30%
Jun 30, 2023 -30.71%
Mar 31, 2023 75.42%
Dec 31, 2022 -42.60%
Sep 30, 2022 -46.17%
Jun 30, 2022 -23.54%
Mar 31, 2022 299.82%
Dec 31, 2021 -48.43%
Sep 30, 2021 -53.52%
Jun 30, 2021 -57.73%